Debby Thomas - Search Results

Year	Number of Results
2011	2
2012	2
2013	2
2014	2
2015	1
2017	2
2019	1
2020	4
2021	6
2022	8
2023	9
2024	3

1

Blocking interleukin-17 in psoriasis: Real-world experience from the PsoPlus cohort.

Schots L, Soenen R, Blanquart B, Thomas D, Lambert J. Schots L, et al. Among authors: thomas d. J Eur Acad Dermatol Venereol. 2023 Apr;37(4):698-710. doi: 10.1111/jdv.18827. Epub 2023 Jan 13. J Eur Acad Dermatol Venereol. 2023. PMID: 36562700 Clinical Trial.

2

Achieving Mucosal Healing in Inflammatory Bowel Diseases: Which Drug Concentrations Need to Be Targeted?

Van den Berghe N, Gils A, Thomas D. Van den Berghe N, et al. Among authors: thomas d. Clin Pharmacol Ther. 2019 Nov;106(5):945-954. doi: 10.1002/cpt.1609. Epub 2019 Sep 20. Clin Pharmacol Ther. 2019. PMID: 31420861 Free PMC article. Review.

3

Formation and clearance of TNF-TNF inhibitor complexes during TNF inhibitor treatment.

Berkhout LC, I'Ami MJ, Kruithof S, Vogelzang EH, Hooijberg F, Hart MHL, Bentlage AEH, Thomas D, Vermeire S, Vidarsson G, Ten Brinke A, Nurmohamed MT, Wolbink GJ, Rispens T. Berkhout LC, et al. Among authors: thomas d. Br J Pharmacol. 2024 Apr;181(8):1165-1181. doi: 10.1111/bph.16269. Epub 2023 Dec 5. Br J Pharmacol. 2024. PMID: 37859583

4

Combined deficient response to polysaccharide-based and protein-based vaccines predicts a severe clinical phenotype.

Cockx M, Haerynck F, Hoste L, Schrijvers R, Van der Werff Ten Bosch J, Dillaerts D, Thomas D, Schaballie H, Bucciol G, Robberechts W, Patel D, Berbers G, Desombere I, Geukens N, Meyts I, Bossuyt X. Cockx M, et al. Among authors: thomas d. Clin Chem Lab Med. 2023 Sep 21;62(1):138-149. doi: 10.1515/cclm-2023-0626. Print 2024 Jan 26. Clin Chem Lab Med. 2023. PMID: 37731388

5

A Model-Based Tool for Guiding Infliximab Induction Dosing to Maximize Long-term Deep Remission in Children with Inflammatory Bowel Diseases.

Kantasiripitak W, Wicha SG, Thomas D, Hoffman I, Ferrante M, Vermeire S, van Hoeve K, Dreesen E. Kantasiripitak W, et al. Among authors: thomas d. J Crohns Colitis. 2023 Jun 16;17(6):896-908. doi: 10.1093/ecco-jcc/jjad009. J Crohns Colitis. 2023. PMID: 36661279

6

Detection of Breast Cancer-Specific Extracellular Vesicles with Fiber-Optic SPR Biosensor.

Yildizhan Y, Driessens K, Tsao HSK, Boiy R, Thomas D, Geukens N, Hendrix A, Lammertyn J, Spasic D. Yildizhan Y, et al. Among authors: thomas d. Int J Mol Sci. 2023 Feb 13;24(4):3764. doi: 10.3390/ijms24043764. Int J Mol Sci. 2023. PMID: 36835174 Free PMC article.

7

Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases.

Liefferinckx C, Bottieau J, Toubeau JF, Thomas D, Rahier JF, Louis E, Baert F, Dewint P, Pouillon L, Lambrecht G, Vallée F, Vermeire S, Bossuyt P, Franchimont D. Liefferinckx C, et al. Among authors: thomas d. Inflamm Bowel Dis. 2022 Feb 1;28(2):208-217. doi: 10.1093/ibd/izab042. Inflamm Bowel Dis. 2022. PMID: 33783494

8

Multi-model averaging improves the performance of model-guided infliximab dosing in patients with inflammatory bowel diseases.

Kantasiripitak W, Outtier A, Wicha SG, Kensert A, Wang Z, Sabino J, Vermeire S, Thomas D, Ferrante M, Dreesen E. Kantasiripitak W, et al. Among authors: thomas d. CPT Pharmacometrics Syst Pharmacol. 2022 Aug;11(8):1045-1059. doi: 10.1002/psp4.12813. Epub 2022 Jun 15. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 35706358 Free PMC article.

9

Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model.

Hollevoet K, Thomas D, Compernolle G, Vermeire G, De Smidt E, De Vleeschauwer S, Smith TRF, Fisher PD, Dewilde M, Geukens N, Declerck P. Hollevoet K, et al. Among authors: thomas d. Front Oncol. 2022 Oct 3;12:1017612. doi: 10.3389/fonc.2022.1017612. eCollection 2022. Front Oncol. 2022. PMID: 36263202 Free PMC article.

10

Higher Drug Exposure During the First 24 Weeks of Ustekinumab Treatment Is Associated With Endoscopic Remission in Crohn's Disease.

Van den Berghe N, Verstockt B, Vermeire S, Thomas D, Declerck P. Van den Berghe N, et al. Among authors: thomas d. Clin Gastroenterol Hepatol. 2023 Mar;21(3):838-840.e2. doi: 10.1016/j.cgh.2021.12.020. Epub 2021 Dec 20. Clin Gastroenterol Hepatol. 2023. PMID: 34942369 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year